$64.68
1.211.91%
Ult. Agg.: Oct 30, 4:00 PM
CG Oncology (CGON) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.65 | $-0.55 | $-0.59 | $-0.56 |
| Actual | $-0.90 | $-0.71 | $-0.51 | $-0.57 |
| Surprise | -38.5% | -29.1% | +13.6% | -1.79% |
| Revenue | ||||
| Estimate | $831792 | $512632 | $1.6M | $175536 |
| Actual | $1.2M | $1.1M | $2.3M | $1.7M |
| Surprise | +39.1% | +111.3% | +41.5% | +849.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.82 | $-0.85 | $-0.97 | $-0.89 |
| Revenue | ||||
| Consensus | $643584 | $1.6M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.90 | $-0.65 | -38.5 % |
| Q1 | May 8, 2026 | $-0.71 | $-0.55 | -29.1 % |
| Q4 | Feb 27, 2026 | $-0.51 | $-0.59 | 13.6 % |
| Q3 | Nov 14, 2025 | $-0.57 | $-0.56 | -1.79 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $1.16M | $831.79K | 39.1 % |
| Q1 | May 8, 2026 | $1.08M | $512.63K | 111.3 % |
| Q4 | Feb 27, 2026 | $2.32M | $1.64M | 41.5 % |
| Q3 | Nov 14, 2025 | $1.67M | $175.54K | 849.1 % |